Benson Capital Partners

Developer of a messaging platform designed for improving customer experience through better insights and engagement opportunities The company's platform allows distributors of all sizes to text-enable their location's phone number, allowing contractors to text orders, pictures, and questions to the same number they call, enabling distributors to streamline their customer communications for better workflow, tangible results, and happier customers.

Conserv, a software and sensors business, is changing the art conservation market with a conservation-focused platform that brings together all of the jobs conservation professionals do into a single place. Conserv's initial focus is on environmental monitoring, a non-optional conservation job, where they've developed the only wireless, conservation-focused monitoring system in the space.

AxoSim, Inc. is a biotechnology company based in New Orleans, Louisiana, that specializes in developing innovative platforms for drug discovery in neuroscience. The company offers Nerve-on-a-Chip, a platform designed to predict clinical neurotoxicity and model human neurodegenerative diseases, thereby streamlining the drug development process for biopharmaceutical companies. AxoSim's technologies include NerveSim, which provides an in vitro model featuring Schwann cell myelination and essential metrics for human translation, and BrainSim, which focuses on human-relevant oligodendrocyte myelination. Additionally, AxoSim grows living human cells in a three-dimensional environment that mimics nerve tissue, enhancing the relevance of its models for testing neurotoxicity and related diseases. Founded in 2014, AxoSim aims to advance neuroscience and improve the efficiency of developing effective therapies.